AzTrials
AzTrials

Alveolar Cleft GraftingNCT07612423

Tertiary Alveolar Cleft Reconstruction Using Double Mandibular Cortical Bone Blocks Technique Versus Double Iliac Corticocancellous Bone Blocks Technique

A study testing grafting of the alveolar cleft in people with Alveolar Cleft Grafting, run by Cairo University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The current study aims to compare the double mandibular corticocancellous bone blocks technique with mandibular cancellous bone particles in between versus the double iliac corticocancellous bone blocks technique with iliac cancellous bone particles in between in the tertiary cleft grafting to find out which technique… Read more about this study

Who is it for?
Ages 12 years and older
Conditions the study is for
Alveolar Cleft Grafting
What is being tested?
grafting of the alveolar cleft
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
1 Jun 2026to Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • patients with unilateral alveolar cleft who missed the mixed dentition phase window.
  • patients with previously repaired cleft lip and palate.
  • patients with proper oral hygiene.

Who cannot join

  • Immunocompromised patients.
  • patients with active periodontitis.
  • patients with inadequate oral hygiene.

About this study

Official title: Tertiary Alveolar Cleft Reconstruction Using Double Mandibular Cortical Bone Blocks Technique Versus Double Iliac Corticocancellous Bone Blocks Technique A Randomized Clinical Trial

The current study aims to compare the double mandibular corticocancellous bone blocks technique with mandibular cancellous bone particles in between versus the double iliac corticocancellous bone blocks technique with iliac cancellous bone particles in between in the tertiary cleft grafting to find out which technique maintained better graft width, height, and volume with the least adverse effects after the healing period and hence would allow for restoration of the targeted function and esthetics and improve the cleft patients psychologically and hence improve their quality of life.

Being tested
grafting of the alveolar cleft

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • grafting of the alveolar cleftProcedure or surgery

    patients with unilateral alveolar cleft treated withthe double mandibular corticocancellous bone blocks technique with mandibular cancellous bone particles in between.

  • grafting of the alveolar cleftProcedure or surgery

    grafting alveolar cleft with double iliac corticocancellous bone blocks technique with cancellous bone particles in between

Study groups in NCT07612423
Study groupRoleWhat they receive
Intervention group / Study groupExperimentalPatients with unilateral alveolar cleft beyond mixed dentition treated with the double mandibular corticocancellous bone blocks technique with mandibular cancellous bone particles in between
Receives: Procedure: grafting of the alveolar cleft
Control groupActive comparatorPatients with unilateral alveolar cleft beyond mixed dentition treated with the double iliac corticocancellous bone blocks technique with iliac cancellous bone particles in between.
Receives: Procedure: grafting of the alveolar cleft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of gained bone volume after 6 months of graft healing in cubic millimeter by CBCT analysis

    Measurement of gained bone volume after 6 months of graft healing in cubic millimeter by comparison between CBCT scans that will be taken postoperatively, and after 6 months postoperatively. volume assessment will be by specialized software 3D Slicer

    Measured: 6 months

Secondary outcomes (1)
  1. Measurement of gained bone labio-palatal width and height in millimeter by CBCT analysis

    Measurement of gained bone labio-palatal width and height in millimeter after 6 months of graft healing by comparison between CBCT scans that will be taken postoperatively, and after 6 months postoperatively by specialized software Atomica ai.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2026
  2. Study start1 Jun 2026 (estimated)
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07612423
Sponsor's protocol ID
261226
Status last verified
May 2026
First submitted
19 May 2026
Last updated
26 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing grafting of the alveolar cleft in people with Alveolar Cleft Grafting, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of gained bone volume after 6 months of graft healing in cubic millimeter by CBCT analysis (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in